Observational studyFrontiers in endocrinology2026
Dapagliflozin and linagliptin combination therapy improves time in range and reverses hepatic steatosis in patients with type 2 diabetes and hypertension.
WenXia Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.